CD28 and neoplasm: Third-generation CARs consist of two signaling domains and a CD3ζ chain such as the CD3ζ-CD28-OX40, which, compared to second-generation CARs, have increased activation signals, the length of the proliferation period, cytokine production, and effective anti-tumor activity in these cells (133).